Annual Drug Patent Expirations for ZIOPTAN
Zioptan is a drug marketed by Thea Pharma and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ZIOPTAN.
This drug has seventy-seven patent family members in thirty-one countries.
The generic ingredient in ZIOPTAN is tafluprost. Two suppliers are listed for this compound. Additional details are available on the tafluprost profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
